4th Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$930,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

11 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

- HR 1249, "The America Invents Act", regarding all provisions.

LobbyistCovered position, as disclosed
CHARLES NAU —

Contacted: SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1249 (112th)

Financial Institutions/Investments/Securities FIN

- HR 1062, "The Burdensome Data Collection Relief Act", regarding all provisions.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Bills named: H.R. 1062 (112th)

Trade (domestic/foreign) TRD

- Korea-US Free Trade Agreement - Issues related to current and future trade negotiations. - TransPacific Partnership trade negotiations. - Pending legislation regarding the exension of permanent normal trade relations to Russia.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE

Taxation/Internal Revenue Code TAX

- Issues regarding tax reform. - HR 605, "The Patients' Freedom to Choose Act", regarding all provisions. - HR 436, "Protect Medical Innovation Act of 2011", regarding all provisions. - HR 488, "Save Our Medical Devices Act of 2011", regarding all provisions. - HR 734, "To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes", regarding all provisions. - S 17, "Medical Device Access and Innovation Protection Act", regarding all provisions. - S 262, "A bill to repeal the excise tax on medical device manufacturers", regarding all provisions. - HR 942, "American Research and Competitiveness Act of 2011", regarding all provisions - Issues related to tax legislation. - Issues related to the President's proposed "Job Bill" (2011) - S 1368/ HR 2529, "Restoring Access to Medication Act", regarding all provisions. - S 1584, "Drug Safety and Accountability Act of 2011", regarding all provisions. - HR 2245, "Preserving Access to Life-Saving Medication Act", regarding all provisions. - Issues related to Ways and Means tax reform discussion draft. - HR 2735, "To amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations", regarding all provisions. - S 1577, "Greater Research Opportunities With Tax Help Act", regarding all provisions.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DON BOHN —
BRIAN BURNS —
JULIE D COHEN —
DARREL C JODREY —
DAVID KAVANAUGH New —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE

Bills named: H.R. 734 (112th), H.R. 488 (112th), H.R. 605 (112th), H.R. 942 (112th), H.R. 2245 (112th), H.R. 436 (112th), H.R. 2529 (112th), H.R. 2735 (112th)

Medicare/Medicaid MMM

- HR 905/ S 733, "To Amend Part B or Title XVIII of the Social Security Act to exclude customary prompt pay discounts from Manufacturers to Wholesalers from the average sales price for drugs & biologicals under Medicare", regarding all provisions. - HR 1041, "The Fairness in Medicare Bidding Act", regarding all provisions. - HR 1041, "Fairness in Medicare Bidding Act", regarding all provisions. - Medicare Part D Letter - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - S 668, "Health Care Bureaucrats Elimination Act", regarding all provisions. - Issues related to Physician-owned Companies that manufacture or distribute medical devices. - S 1468/ HR 2787, "Medicare Diabetes Self-Management Training Act of 2011", regarding all provisions.

LobbyistCovered position, as disclosed
LAURYL DODSON JACKSON —
MARK REESE —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE

Bills named: H.R. 452 (112th), H.R. 905 (112th), H.R. 1041 (112th), H.R. 2787 (112th)

Budget/Appropriations BUD

- Issues related to ADAP funding. - Issues related to the Joint Committe on Deficit Reduction. - Issues related to FDA funding.

LobbyistCovered position, as disclosed
BRIAN BURNS —
JULIE D COHEN —
DARREL C JODREY —
CHARLES NAU —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Consumer Issues/Safety/Products CSP

- Issues related to dextromethorphan - Issues related to Pseudoephedrine - Issues related to the regulation of Cosmetic Products. - HR 2359, "Safe Cosmetics Act of 2011", regarding all provisions.

LobbyistCovered position, as disclosed
GREGORY ARONIN New —
DON BOHN —
DARREL C JODREY —

Contacted: SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 2359 (112th)

Torts TOR

- HR 5, "Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011", regarding all provisions. - HR 675, "Strengthening Medicare Anti-Fraud Measures Act of 2011", regarding all provisions. - Issues regarding Health Courts

LobbyistCovered position, as disclosed
GREGORY ARONIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Bills named: H.R. 5 (112th), H.R. 675 (112th)

Law Enforcement/Crime/Criminal Justice LAW

- Issues regarding the theft of medical products. - S. 1002, "SAFE DOSES Act", regarding all provisions.

LobbyistCovered position, as disclosed
MARK REESE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Bills named: S. 1002 (112th)

Health Issues HCR

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - Issues related to the Better Act - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Physician Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3209, "Premarket Predictability Act of 2011", regarding all provisions. - HR 3203/ S 1943, "Novel Device Regulatory Relief Act of 2011", regarding all provisions. - HR 3230, "Keeping America Competitive Through Harmonization Act of 2011", regarding all provisions. - HR 3211, "Humanitarian Device Reform Act of 2011", regarding all provisions. - HR 3208, "Patients Come First Act of 2011", regarding all provisions. - HR 3206, "Cultivating Scientific Expertise to Foster Inovation for Patients Act of 2011", regarding all provisions. - HR 3214/ S 1972, "Food and Drug Administration Mission Reform Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - HR 3204, "Guidance Accountability and Transparency Act of 2011", regarding all provisions. - HR 3205, "FDA Renewing Efficiency From Outside Reviewer Management Act of 2011", regarding all provisons. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
BRIAN BURNS —
JULIE D COHEN —
LAURYL DODSON JACKSON —
DARREL C JODREY —
CHARLES NAU —
MARK REESE —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 3026 (112th), H.R. 3214 (112th), H.R. 3205 (112th), H.R. 3497 (112th), H.R. 2939 (112th), H.R. 2960 (112th), H.R. 3207 (112th), H.R. 3208 (112th), H.R. 3230 (112th), H.R. 3206 (112th), H.R. 3211 (112th), H.R. 1282 (112th), H.R. 3209 (112th), H.R. 3204 (112th), H.R. 3203 (112th)

Environment/Superfund ENV

- Issues related to chemicals in the environment - Issues related to the Toxic Substances Control Act - S. 847, "Safe Chemicals Act of 2011", regarding all provisions.

LobbyistCovered position, as disclosed
GREGORY ARONIN —
DARREL C JODREY —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Bills named: S. 847 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.